# COMPARE ONE-PAGER (CROSS-INDUSTRY READY)

## HEADER
Ticker: OMED
Company: PT Jayamas Medica Industri Tbk
Sector: Healthcare
Industry: Medical Instruments & Supplies
AsOf: 2025-09-12

## VALUATION
Market Cap: IDR 5.11 triliun
PER: 15.8x
PBV: 2.0x
Dividend Yield: 1.9%

## PROFITABILITY
Revenue Growth YoY: +8.6%
Net Profit Growth YoY: +24.2%
Net Margin: 17.2%
ROE: 13%
ROA: 5.5%

## BALANCE & CASH
DER: 0.11x
FCF: IDR 255 miliar

## SCORE (0â€“5 each; integers or 0.5 steps allowed)
ValuationScore: 3.5
ProfitabilityScore: 4
BalanceScore: 4
IncomeScore: 2.5

## NOTES
Highlights:
- Revenue and net profit grew strongly YoY (+8.6% and +24.2%)
- Debt reduced after full MTN repayment, lowering interest expense

Risks:
- High dependence on imported raw materials exposes to forex risk
- Weakening IDR could pressure margins if not offset by local sourcing

## METADATA
Source: Company filings, IDX, OMED financials
Period: Q2 2025 YTD / FY 2024
LastUpdate: 2025-09-12